tretoquinol has been researched along with Parkinson Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Contu, VR; Kotake, Y; Kumagai, Y; Miyara, M; Ohta, S; Okuda, K; Sakamoto, S; Samizo, S; Sanoh, S; Toyama, T | 1 |
1 other study(ies) available for tretoquinol and Parkinson Disease
Article | Year |
---|---|
Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.
Topics: Animals; Blotting, Western; Catechols; Cell Line, Tumor; Cell Survival; Dopamine; Electrophoresis, Agar Gel; Escherichia coli; Humans; Indicators and Reagents; Mesencephalon; Mice; Mice, Inbred C57BL; Models, Molecular; Neurotoxins; Parkinson Disease; Protein Binding; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tretoquinol; Ubiquitin Thiolesterase | 2014 |